Protocol Memory Deficit in Patients With Obstructive Sleep Apnea Syndrome
Status
Conditions
Treatments
Details and patient eligibility
About
The main objective of this study is to evaluate the evolution of memory deficit (verbal episodic memory, procedural memory, working memory, short-term memory) in Sleep Apnea Obstructive Syndrome (SAOS) patients after treatment by Continuous Positive Airway Pressure treatment (CPAP). For thus, we will compare memory tests in two separate groups of SAOS patients with "effective " versus "ineffective" ( or sham) CPAP, before and 6 weeks after the beginning of the treatment. Thus we will assess the evolution of memory deficit, the effectiveness of the treatment on the evolution of memory deficit before and 6 weeks after the beginning of the treatment by "effective " versus "ineffective" CPAP.
We feel the results of the tests of memory will show greater memory disorders in patients with SAOS before beginning the treatment rather than six weeks afterwards. Thus we hypothesise that, after the treatment by "effective" CPAP, the patients with SAOS will have greater improvement of their memory disorders than those treated by "sham CPAP".
Full description
We want to assess the evolution, before and 6 weeks after the beginning of the treatment, of the significant differences of the performances of the various memory tests evaluating several forms of memory (episodic memory, working memory, short-term memory and procedural memory) according to the treatment for patients with SAOS (effective versus sham).
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
- Major patients,
- agreeing,
- diagnosed suffering from the SAOS,
- regulation by the specialist in a treatment by CPAP,
- patients do not begin the treatment
- affiliated to the social security,
- fluent in French.
Exclusion criteria
- Patients presenting severe depressive disorders (HADS score>19),
- intellectual deterioration (MMS< 28),
- a functional failure of the dominant arm upper limb inhibiting realization of graphic tasks,
- an associated oxygen treatment,
- suffering from cancer,
- cerebro-vascular accident,
- pregnant or nursing women,
- adult under supervision or trusteeship,
- patients already included in another research protocol or in period of exclusion,
- antidepressant and anxiolytic treatment.
Trial design
Primary purpose
Allocation
Interventional model
Masking
40 participants in 2 patient groups
Trial contacts and locations
Loading...
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal